脊髓损伤患者自报处方氢可酮、羟考酮与曲马多使用与非故意伤害的关系
本研究为横断面队列研究,纳入918例慢性创伤性脊髓损伤成人,评估氢可酮、羟考酮和曲马多使用与过去一年非故意伤害(含跌倒相关与非跌倒相关)的关系。结果显示仅氢可酮与任何非故意伤害相关,三种阿片类药物均与跌倒相关伤害显著相关,提示伤害预防需考虑阿片类药物的潜在影响。
要点
- 氢可酮偶用或常规使用均与过去一年非故意伤害风险升高相关。
- 氢可酮偶用还与非跌倒相关伤害风险升高相关。
- 氢可酮、羟考酮和曲马多均与跌倒相关伤害风险显著相关。
核心结论
- 伤害预防工作必须考虑阿片类药物使用的潜在影响,尤其是氢可酮。
- 为预防跌倒相关伤害,必须考虑氢可酮、羟考酮和曲马多这三种阿片类药物。
研究设计与样本
- 横断面队列研究,纳入918例来自专科医院和州人口登记、完成自报评估的慢性创伤性脊髓损伤成人。
主要发现
- 超过20%的参与者报告过去一年至少1次非故意伤害,其中报告至少1次伤害者的平均伤害次数为2.16次。
- 9.6%的参与者报告跌倒相关伤害。
- 仅氢可酮与过去一年任何非故意伤害相关:偶用(不超过每月)的比值比为2.63(95%CI 1.52-4.56),常规使用(每周或每日)的比值比为2.03(95%CI 1.15-3.60)。
- 氢可酮偶用与过去一年非跌倒相关伤害相关(OR 2.20;95%CI 1.12-4.31)。
- 三种阿片类药物均与跌倒相关伤害显著相关:氢可酮偶用OR 2.39,常规使用OR 2.31;羟考酮常规使用OR 2.44(95%CI 1.20-4.98);曲马多常规使用OR 2.59(95%CI 1.13-5.90)。
关键数值与推荐
- 氢可酮偶用与过去一年至少1次非故意伤害的OR为2.63(95%CI 1.52-4.56)。
- 氢可酮常规使用与过去一年至少1次非故意伤害的OR为2.03(95%CI 1.15-3.60)。
- 氢可酮偶用与非跌倒相关伤害的OR为2.20(95%CI 1.12-4.31)。
- 氢可酮偶用与跌倒相关伤害的OR为2.39,常规使用OR为2.31。
- 羟考酮常规使用与跌倒相关伤害的OR为2.44(95%CI 1.20-4.98),曲马多常规使用OR为2.59(95%CI 1.13-5.90)。
临床怎么用
- 对使用氢可酮的脊髓损伤患者应加强非故意伤害风险评估与预防教育。
- 对使用氢可酮、羟考酮或曲马多的患者应特别关注跌倒预防措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify the relations of 3 frequently used prescription opioids (hydrocodone, oxycodone, tramadol) with unintentional injuries, including fall-related and non-fall-related injuries among adults with chronic, traumatic spinal cord injury (SCI). DESIGN: Cross-sectional cohort study. SETTING: Community setting; Southeastern United States. PARTICIPANTS: Adult participants (N=918) with chronic traumatic SCI were identified from a specialty hospital and state population-based registry and completed a self-report assessment. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Self-reported fall-related and non-fall-related unintentional injuries serious enough to receive medical care in a clinic, emergency room, or hospital within the previous 12 months. RESULTS: Just over 20% of participants reported ≥1 unintentional injury in the past year, with an average of 2.16 among those with ≥1. Overall, 9.6% reported fall-related injuries. Only hydrocodone was associated with any past-year unintentional injuries. Hydrocodone taken occasionally (no more than monthly) or regularly (weekly or daily) was related to 2.63 (95% confidence interval [CI], 1.52-4.56) or 2.03 (95% CI, 1.15-3.60) greater odds of having ≥1 unintentional injury in the past year, respectively. Hydrocodone taken occasionally was also associated with past-year non-fall-related injuries (OR, 2.20; 95% CI, 1.12-4.31). Each of the 3 opioids was significantly related to fall-related injuries. Taking hydrocodone occasionally was associated with 2.39 greater odds of fall-related injuries, and regular use was associated with 2.31 greater odds. Regular use of oxycodone was associated with 2.44 odds of a fall-related injury (95% CI, 1.20-4.98), and regular use of tramadol was associated with 2.59 greater odds of fall-related injury (95% CI, 1.13-5.90). CONCLUSIONS: Injury prevention efforts must consider the potential effect of opioid use, particularly hydrocodone. For preventing fall-related injuries, each of the 3 opioids must be considered.
引用
- Krause JS, DiPiro ND, Dismuke-Greer CE, et al. Relations Between Self-reported Prescription Hydrocodone, Oxycodone, and Tramadol Use and Unintentional Injuries Among Those With Spinal Cord Injury. Arch Phys Med Rehabil. 2024. PMID: 38762197. doi:10.1016/j.apmr.2024.05.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。